Alembic Pharmaceuticals gets USFDA final approval for ANDA Docetaxel Injection
Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application Docetaxel Injection.
Source: equitybulls.com